Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

ACARBOSE FOR IDENTIFICATION CRS (10 MG)

ACARBOSE FOR IDENTIFICATION CRS (10 MG)

56180-94-0

DISCOVER
POLYMYXIN B SULFATE FOR MICROBIOLOGICAL ASSAY CRS (25 MG)

POLYMYXIN B SULFATE FOR MICROBIOLOGICAL ASSAY CRS (25 MG)

1405-20-5

DISCOVER
CLOFAZIMINE FOR SYSTEM SUITABILITY CRS (10 MG)

CLOFAZIMINE FOR SYSTEM SUITABILITY CRS (10 MG)

2030-63-9

DISCOVER
ACEBUTOLOL IMPURITY B CRS (15MG)

ACEBUTOLOL IMPURITY B CRS (15MG)

NA

DISCOVER
Ciclosporin for system suitability CRS, 1mg

Ciclosporin for system suitability CRS, 1mg

59865-13-3

DISCOVER
CIPROFIBRATE CRS (5 MG)

CIPROFIBRATE CRS (5 MG)

52214-84-3

DISCOVER
Ciprofibrate for system suitability CRS, 5mg

Ciprofibrate for system suitability CRS, 5mg

52214-84-3

DISCOVER
CLIOQUINOL CRS (5 MG)

CLIOQUINOL CRS (5 MG)

130-26-7

DISCOVER
DODECYL GALLATE CRS (30 MG)

DODECYL GALLATE CRS (30 MG)

1166-52-5

DISCOVER
ISRADIPINE CRS (125 MG)

ISRADIPINE CRS (125 MG)

75695-93-1

DISCOVER
ISRADIPINE IMPURITY D CRS (5 MG)

ISRADIPINE IMPURITY D CRS (5 MG)

NA

DISCOVER
OCTYL GALLATE CRS (30 MG)

OCTYL GALLATE CRS (30 MG)

1034-01-1

DISCOVER